Mostrando resultados 41 - 50 de 279.
Search results
The NM4T group develops new therapeutic strategies based on nanotechnology. We work with synthetic nanoparticles and extracellular vesicles (EV) that…
With a medicinal chemistry background, the group focuses on drug discovery projects aimed at developing innovative drug strategies to combat cancer.…
The NMR and molecular recognition (NMR) group began at the CIB in 2003 with the incorporation of Drs Jesús Jiménez Barbero and Fco. Javier Cañada to…
The pharmacological regulation of the cytoskeleton has been crucial in the development of cancer treatments and currently, it is considered a novel…